87 related articles for article (PubMed ID: 31051970)
21. Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.
Reddy NM; Nori D; Chang H; Lange CS; Ravi A
Med Phys; 2010 Jul; 37(7):3791-801. PubMed ID: 20831087
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies.
Georg P; Georg D; Hillbrand M; Kirisits C; Pötter R
Radiother Oncol; 2006 Jul; 80(1):19-26. PubMed ID: 16766068
[TBL] [Abstract][Full Text] [Related]
23. A treatment planning approach to spatially fractionated megavoltage grid therapy for bulky lung cancer.
Costlow HN; Zhang H; Das IJ
Med Dosim; 2014; 39(3):218-26. PubMed ID: 24833301
[TBL] [Abstract][Full Text] [Related]
24. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
25. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric advantage and clinical implication of a micro-multileaf collimator in the treatment of prostate with intensity-modulated radiotherapy.
Wang L; Hoban P; Paskalev K; Yang J; Li J; Chen L; Xiong W; Ma CC
Med Dosim; 2005; 30(2):97-103. PubMed ID: 15922176
[TBL] [Abstract][Full Text] [Related]
27. The Impact of the Grid Size on TomoTherapy for Prostate Cancer.
Kawashima M; Kawamura H; Onishi M; Takakusagi Y; Okonogi N; Okazaki A; Sekihara T; Ando Y; Nakano T
J Med Phys; 2017; 42(3):144-150. PubMed ID: 28974860
[TBL] [Abstract][Full Text] [Related]
28. ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription.
Yaparpalvi R; Hong L; Mah D; Shen J; Mutyala S; Spierer M; Garg M; Guha C; Kalnicki S
Radiother Oncol; 2008 Dec; 89(3):347-52. PubMed ID: 18762345
[TBL] [Abstract][Full Text] [Related]
29. A margin-of-the-day online adaptive intensity-modulated radiotherapy strategy for cervical cancer provides superior treatment accuracy compared to clinically recommended margins: a dosimetric evaluation.
Ahmad R; Bondar L; Voet P; Mens JW; Quint S; Dhawtal G; Heijmen B; Hoogeman M
Acta Oncol; 2013 Oct; 52(7):1430-6. PubMed ID: 23902275
[TBL] [Abstract][Full Text] [Related]
30. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
31. Bag and loop small bowel contouring strategies differentially estimate small bowel dose for post-hysterectomy women receiving pencil beam scanning proton therapy.
Xu MJ; Kirk M; Zhai H; Lin LL
Acta Oncol; 2016 Jul; 55(7):900-8. PubMed ID: 26927612
[TBL] [Abstract][Full Text] [Related]
32. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
33. Bladder dose accumulation based on a biomechanical deformable image registration algorithm in volumetric modulated arc therapy for prostate cancer.
Andersen ES; Muren LP; Sørensen TS; Noe KO; Thor M; Petersen JB; Høyer M; Bentzen L; Tanderup K
Phys Med Biol; 2012 Nov; 57(21):7089-100. PubMed ID: 23051686
[TBL] [Abstract][Full Text] [Related]
34. IMRT to escalate the dose to the prostate while treating the pelvic nodes.
Cavey ML; Bayouth JE; Colman M; Endres EJ; Sanguineti G
Strahlenther Onkol; 2005 Jul; 181(7):431-41. PubMed ID: 15995836
[TBL] [Abstract][Full Text] [Related]
35. Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer.
Stasi M; Munoz F; Fiorino C; Pasquino M; Baiotto B; Marini P; Malinverni G; Valdagni R; Gabriele P
Radiother Oncol; 2006 Sep; 80(3):363-70. PubMed ID: 16959344
[TBL] [Abstract][Full Text] [Related]
36. Independent calculation-based verification of IMRT plans using a 3D dose-calculation engine.
Arumugam S; Xing A; Goozee G; Holloway L
Med Dosim; 2013; 38(4):376-84. PubMed ID: 23790325
[TBL] [Abstract][Full Text] [Related]
37. A method for a priori estimation of best feasible DVH for organs-at-risk: Validation for head and neck VMAT planning.
Ahmed S; Nelms B; Gintz D; Caudell J; Zhang G; Moros EG; Feygelman V
Med Phys; 2017 Oct; 44(10):5486-5497. PubMed ID: 28777469
[TBL] [Abstract][Full Text] [Related]
38. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
[TBL] [Abstract][Full Text] [Related]
39. Methods, software and datasets to verify DVH calculations against analytical values: Twenty years late(r).
Nelms B; Stambaugh C; Hunt D; Tonner B; Zhang G; Feygelman V
Med Phys; 2015 Aug; 42(8):4435-48. PubMed ID: 26233174
[TBL] [Abstract][Full Text] [Related]
40. The effect of slice thickness on target and organs at risk volumes, dosimetric coverage and radiobiological impact in IMRT planning.
Srivastava SP; Cheng CW; Das IJ
Clin Transl Oncol; 2016 May; 18(5):469-79. PubMed ID: 26311077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
